Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
F14 (celecoxib) for Postoperative Pain in TKR
NCT03541655Phase 2Completed
- Sponsor
- Arthritis Innovation Corporation
- Start
- May 2018
- Primary completion
- Jun 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in postoperative pain comparing F14 (celecoxib) with Standard of care analgesia (2 arms). Primary endpoints: Peak pain intensity measured by visual analog scale at 2 weeks, Area under the curve of visual analog scale pain intensity scores at 72 hours and 3 more. Started May 2018; status: completed.
02
Drugs
celecoxib
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03541655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03541655.